SCHEMBL1245306

SCHEMBL1245306

[CH2]C/C(C)=[C]/C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2501041 0.73
SCHEMBL27559391 0.71
SCHEMBL11830557 0.69
SCHEMBL8959739 0.67
SCHEMBL2850341 0.67
SCHEMBL23612 0.67
SCHEMBL4386057 0.67
SCHEMBL487128 0.67
SCHEMBL23611 0.67
SCHEMBL4386054 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170355642-A1 MONO- AND BISALKYLENETRIALKOXYSILANE DISPERSANTS FOR HYDRAULIC BINDERS BASF SE (DE) 2017-12-14 US disclosed
EP-2464340-A2 PHARMACEUTICAL COMPOSITIONS WITH TETRABENAZINE Valeant International (Barbados) SRL (BB) 2012-06-20 EP disclosed
WO-2011019956-A2 PHARMACEUTICAL COMPOSITIONS BIOVAIL LABORATORIES INTERNATIONAL (BARBADOS) S.R.L. (BB) 2011-02-17 WO disclosed
EP-2214650-A2 BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS Biovail Laboratories International SRL (BB) 2010-08-11 EP disclosed
EP-2185139-A2 BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS BIOVAIL LABORATORIES INTERNATIONAL SRL (BB) 2010-05-19 EP disclosed
WO-2010018408-A2 PHARMACEUTICAL COMPOSITIONS BIOVAIL LABORATORIES INTERNATIONAL (BARBADOS) SRL (BB) 2010-02-18 WO disclosed
WO-2010015692-A2 BUPROPION HYDROBROMIDE POLYMORPHS BIOVAIL LABORATORIES INTERNATIONAL SRL (BB) 2010-02-11 WO disclosed
WO-2009019294-A9 BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS BIOVAIL LAB INT SRL (BB) 2009-06-11 WO disclosed
WO-2009056550-A2 BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS BIOVAIL LABORATORIES INTERNATIONAL SRL (BB) 2009-05-07 WO disclosed
WO-2009019294-A2 BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS BIOVAIL LABORATORIES INTERNATIONAL SRL (BB) 2009-02-12 WO disclosed
EP-1896002-A2 MODIFIED-RELEASE FORMULATIONS OF A BUPROPION SALT BIOVAIL LABORATORIES INTERNATIONAL SRL (BB) 2008-03-12 EP disclosed
WO-2007078895-A2 MODIFIED RELEASE FORMULATIONS OF TRAMADOL AND USES THEREOF BIOVAIL LABORATORIES INTERNATIONAL S.R.L. (BB) 2007-07-12 WO disclosed
WO-2007002597-A2 MODIFIED-RELEASE FORMULATIONS OF A BUPROPION SALT BIOVAIL LABORATORIES INTERNATIONAL S.R.L. (BB) 2007-01-04 WO disclosed
WO-1996041621-A2 OSMOTIC-DELIVERY DEVICES HAVING VAPOR-PERMEABLE COATINGS S.C. JOHNSON & SON, INC. (US) 1996-12-27 WO disclosed
EP-0513580-B1 Alpha-phenyl-acrylic acid derivatives, process for their preparation and their use as parasiticides and fungicides BASF AG (DE) 1996-10-23 EP disclosed
US-5416068-A Alpha-phenylacrylic acid derivatives, their preparation and their use for controlling pests and harmful fungi BASF AKTIENGESELLSCHAFT (DE) 1995-05-16 US disclosed
US-5298527-A Insecticides BASF AKTIENGESELLSCHAFT (DE) 1994-03-29 US disclosed
EP-0513580-A2 Alpha-phenyl-acrylic acid derivatives, process for their preparation and their use as parasiticides and fungicides BASF Aktiengesellschaft (DE) 1992-11-19 EP disclosed